onjunctival melanoma (CM) is a rare but potentially deadly ocular malignant condition, with a 10-year disease-specific mortality of 9% to 35%.
which adheres to the tenets of the Declaration of Helsinki and is compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Per institutional review board approval, the use of archival samples obviated the need for the informed consent of the included patients.
The University of Miami Sequencing Core facility conducted the WES using the customized bioinformatic pipeline of the present study, with a mean exome coverage target of ×60. Sequences were aligned to the human reference genome GRCh37/hg19 using NovoAlign (Novocraft Technologies Sdn Bhd). Since matched blood samples were not available, we used a panel of normal tissue samples (n = 117), a high-coverage blood sample, and somatic single-nucleotide and insertion and deletion (indel) variant-caller MuTect2 to call out tumor variants and filter out likely silent germline polymorphisms. 4 To minimize artifacts introduced by the specimen archiving process, we filtered out all genetic variants present in less than 20% of sequencing reads. Additionally, variants were excluded if they were outside of coding or splicing regions, had fewer than 3 alternate reads, were present in greater than 0.5% of the population, or were predicted to be nondamaging using ANNOVAR (Children's Hospital of Philadelphia, Pennsylvania). Chromosome copy number aberrations were assessed using CNVkit (University of California, San Francisco) and Genomic Identification of Significant Targets in Cancer (GISTIC) version 2.0 (Broad Institute), whereas mutation signatures were analyzed using pmsignature (the University of Chicago) in R (R Development Core Team). Additional details are available in the Supplement in the eAppendix.
Results
All patients were white, and none had a history of cutaneous melanoma or uveal melanoma. Two of the 5 patients (40%) had CM that arose from primary acquired melanosis; all lesions arose on sun-exposed areas. Four of the 5 patients had bulbar CM (located within the conjunctiva covering the globe) and the remaining individual had palpebral CM (located within the tarsal conjunctiva of the eyelid). None of the 5 patients had had treatment of their disease prior to receiving care at the center where the archiving of their samples occurred. Clinical features are further summarized in the Table. Deleterious mutations were identified in all 5 CM samples ( Figure) . These mutations included BRAF V600E, BRAF V600K, and NRAS Q61R, which have been reported previously in CM and cutaneous melanoma. 5, 6 One sample (patient 2) harbored a mutation in the tumor suppressor NF1 (without systemic manifestations), which previously has been reported in CM only in association with neurofibromatosis. 7 Mutations previously unreported in CM occurred in other cancer-associated genes, including APC (n=2),EGFR (n = 1), CBL (n = 1), and ALK (n = 1). In cutaneous melanoma as well as CM, 8 TERT mutations have been found to occur in the promoter sequence, thereby altering messenger RNA expression, whereas the TERT mutation in the present case was a missense alteration within the coding sequence and was therefore predicted to alter protein function. Mutations were also found in epigenetic regulators, including TET2 (n=1),ATRX (n = 1), and ASXL1 (n = 1). The gene ASXL1 encodes a protein-binding partner of BAP1, a gene that is commonly mutated in uveal melanoma 9 ; however, no samples contained mutations in BAP1 or other genes commonly mutated in uveal melanoma. 10 
Discussion
Several of these mutations could nominate new therapeutic options. The mutations in BRAF, NRAS, and NF1 activate the mitogen-activated protein kinase (MAPK) pathway, which can be pharmacologically inhibited with mitogen-activated protein kinase kinase (MEK) inhibitors. 11 The mutations in APC,
Key Points
Question What mutations can be identified with whole-exome sequencing (WES) of conjunctival melanoma (CM)?
Findings With WES, CM was found to harbor mutations in BRAF, NRAS, and NF1; previously unreported mutations in EGFR, APC, TERT and other cancer-associated genes; and the C→T mutation signature consistent with UV-induced DNA damage. The most common chromosomal alteration was 6p gain.
Meaning Whole-exome sequencing might enable the detection of molecular mutations targetable by cancer therapies and provide insight into the pathogenesis of CM. EGFR, and ALK can be inhibited with other targeted molecular agents.
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The role of UV light in the pathogenesis of CM has been the subject of discussion. 13 However, consistent with a recent report, 14 we observed in all 5 cases a prominent C→T mutation signature associated with UV light-induced DNA damage ( Figure) , which strongly implicates UV light as a mutagen in CM. The C→T mutations are important in UV-driven malignant conditions. Notably, non-UV-exposed conjunctival melanomas with KIT mutations have also been described, particularly in Chinese populations. 2 The only CNA identified in all 5 samples was a chromosome 6p gain, which is also common in cutaneous melanoma and uveal melanoma. However, other recurrent CNAs were observed (Figure; eTables 1-4 in the Supplement). Samples from patients 1, 3, and 5 appeared to have a lower mutational burden than those found inmucosal melanomas in other locations, as previously described. 15 Interestingly, the 2 samples from individuals who experienced rapid recurrences within a year (patient 2 and patient 4) had the greatest number of mutations ( Figure) and the largest amount of CNAs ( Figure) , suggesting that WES data may be valuable in predicting clinical outcome. This is an interesting observation that deserves further evaluation.
Limitations
Limitations of the present study include the small number of samples. In addition, 2 of 5 cases (40%) arose from primary acquired melanosis, which is thought to serve as the origin of malignant transformation in 75% of CM cases. 1 It is possible that the mutational signatures of de novo CM observed in this study may differ from those arising from primary acquired melanosis. In addition, the location of the tumor (bulbar vs palpebral) may carry distinct signatures as well, given that the areas experience differences in exposure to UV light. All of the CM samples in this series occurred in sun-exposed areas. Larger studies would be appropriate for further evaluation of these potential distinctions.
Conclusions
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